Mechanisms and treatment of atherosclerosis: focus on macrophages

LingNa Zhang1, JiaWei Li1, YuShun Kou1

  • 1School of Traditional Chinese and Western Medicine, Gansu University of Chinese Medicine, Lanzhou, Gansu, China.

Frontiers in Immunology
|November 21, 2024
PubMed

Insights

Macrophages are key in chronic inflammation and atherosclerosis (AS). New therapies targeting macrophage polarization, including Traditional Chinese Medicine, offer personalized approaches beyond statins for AS treatment.

Area of Science:

  • Immunology
  • Cardiovascular Disease Research
  • Pharmacology

Background:

  • Macrophages are central to chronic inflammation and atherosclerosis (AS) development.
  • Macrophage polarization into M1 and M2 phenotypes differentially impacts AS initiation and progression.
  • Current lipid-lowering drugs like statins have limitations, including adverse effects and lack of personalized treatment.

Purpose of the Study:

  • To explore the role of macrophage polarization in atherosclerosis.
  • To investigate novel therapeutic strategies targeting macrophages in AS.
  • To evaluate the potential of Traditional Chinese Medicine (TCM) in modulating macrophage phenotypes for AS treatment.

Main Methods:

  • Review of existing literature on macrophage biology in AS.
  • Analysis of studies on M1 and M2 macrophage roles in atherosclerotic plaque development.
  • Examination of emerging therapies, including TCM, for macrophage-targeted intervention in AS.

Main Results:

  • Macrophages significantly influence chronic inflammation and AS.
  • M1 macrophages promote AS, while M2 macrophages may offer protective effects.
  • Targeted therapies can modulate macrophage polarization, shifting the balance towards M2 phenotypes.

Conclusions:

  • Macrophage polarization is a critical factor in AS pathogenesis.
  • Targeting macrophage phenotypes presents a promising avenue for personalized AS treatment.
  • TCM-based therapies offer novel strategies to regulate macrophage polarization and combat AS.